American Journal of Psychiatry

Papers
(The H4-Index of American Journal of Psychiatry is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?427
Broadening the Parameters of Clinical High Risk for Psychosis349
2024 Annual Meeting: Presidential Address188
Evaluating Associations Between Cannabis and Heroin Use178
Treating Pathologies of the Will171
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia151
Mental Health Disparities Research: An Introduction to New Directions133
Highlights From the Residents’ Journal: December 2021129
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities117
COVID-19 and Stress-Related Disorders115
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now106
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi104
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?103
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial101
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide97
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?90
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology89
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma87
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders86
Intentional Drug Overdose Deaths in the United States82
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis81
Depression, Inflammation, and Postpartum Psychosis81
From Prediction to Action: Moving Beyond Machine Learning to Implementing Evidence-Based Perinatal Mental Health Care79
The First Large GWAS Meta-Analysis for Postpartum Depression78
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression77
Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents77
2024 Annual Meeting: CEO and Medical Director’s Address76
Highlights From the Residents’ Journal: September 202175
Correcting Overestimations in Self-Harm Visit Data74
APA Council Reports71
Highlights From the Residents’ Journal: September 202468
Corrigendum to Morley et al.67
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek67
Correction to Poirot et al.67
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability64
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.64
Suicide and the Menstrual Cycle62
New Insights Into Psychotic Disorders57
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis57
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use57
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression56
Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition56
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials53
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population52
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden51
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia50
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial50
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder50
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience50
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression49
Genetic and Environmental Contribution to the Co-Occurrence of Endocrine-Metabolic Disorders and Depression: A Nationwide Swedish Study of Siblings49
Familial Risk of Postpartum Psychosis49
0.1119179725647